Nanomedicines for the delivery of antimicrobial peptides (AMPs)

Detalhes bibliográficos
Autor(a) principal: Teixeira, Maria C.
Data de Publicação: 2020
Outros Autores: Carbone, Claudia, Sousa, Maria C., Espina, Marta, Garcia, Maria L., Sanchez-Lopez, Elena, Souto, Eliana B.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/64930
Resumo: Microbial infections are still among the major public health concerns since several yeasts and fungi, and other pathogenic microorganisms, are responsible for continuous growth of infections and drug resistance against bacteria. Antimicrobial resistance rate is fostering the need to develop new strategies against drug-resistant superbugs. Antimicrobial peptides (AMPs) are small peptide-based molecules of 5–100 amino acids in length, with potent and broad-spectrum antimicrobial properties. They are part of the innate immune system, which can represent a minimal risk of resistance development. These characteristics contribute to the description of these molecules as promising new molecules in the development of new antimicrobial drugs. However, efforts in developing new medicines have not resulted in any decrease of drug resistance yet. Thus, a technological approach on improving existing drugs is gaining special interest. Nanomedicine provides easy access to innovative carriers, which ultimately enable the design and development of targeted delivery systems of the most efficient drugs with increased efficacy and reduced toxicity. Based on performance, successful experiments, and considerable market prospects, nanotechnology will undoubtedly lead a breakthrough in biomedical field also for infectious diseases, as there are several nanotechnological approaches that exhibit important roles in restoring antibiotic activity against resistant bacteria.
id RCAP_d0900c4be658cb017c70ce5025dc7d64
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/64930
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Nanomedicines for the delivery of antimicrobial peptides (AMPs)antimicrobial peptidesbacterial and virus infectionscoronavirusantimicrobial resistancenanomaterialsnanomedicineScience & TechnologyMicrobial infections are still among the major public health concerns since several yeasts and fungi, and other pathogenic microorganisms, are responsible for continuous growth of infections and drug resistance against bacteria. Antimicrobial resistance rate is fostering the need to develop new strategies against drug-resistant superbugs. Antimicrobial peptides (AMPs) are small peptide-based molecules of 5–100 amino acids in length, with potent and broad-spectrum antimicrobial properties. They are part of the innate immune system, which can represent a minimal risk of resistance development. These characteristics contribute to the description of these molecules as promising new molecules in the development of new antimicrobial drugs. However, efforts in developing new medicines have not resulted in any decrease of drug resistance yet. Thus, a technological approach on improving existing drugs is gaining special interest. Nanomedicine provides easy access to innovative carriers, which ultimately enable the design and development of targeted delivery systems of the most efficient drugs with increased efficacy and reduced toxicity. Based on performance, successful experiments, and considerable market prospects, nanotechnology will undoubtedly lead a breakthrough in biomedical field also for infectious diseases, as there are several nanotechnological approaches that exhibit important roles in restoring antibiotic activity against resistant bacteria.Elena Sanchez-Lopez belongs to 2017SGR-1477. Elena Sanchez-Lopez, Marta Espina and Maria L. GarciaacknowledgethesupportfromtheInstituteofNanoscienceandNanotechnology(ART2018project). Eliana B. Souto acknowledges the Portuguese Science and Technology Foundation (FCT/MCT) and European Funds (PRODER/COMPETE) for the projects M-ERA-NET-0004/2015-PAIRED and UIDB/04469/2020 (strategic fund), co-funded by FEDER, under the partnership Agreement PT2020. Maria C. Teixeira wishes to acknowledge FCT for the individual fellowship (PD/BDE/135086/2017).info:eu-repo/semantics/publishedVersionMDPIUniversidade do MinhoTeixeira, Maria C.Carbone, ClaudiaSousa, Maria C.Espina, MartaGarcia, Maria L.Sanchez-Lopez, ElenaSouto, Eliana B.2020-03-202020-03-20T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/64930engTeixeira, Maria C.; Carbone, Claudia; Sousa, Maria C.; Espina, Marta; Garcia, Maria L.; Sanchez-Lopez, Elena; Souto, Eliana, Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs). Nanomaterials, 10(3), 560, 20202079-499110.3390/nano10030560http://www.mdpi.com/journal/nanomaterialsinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:12:18Zoai:repositorium.sdum.uminho.pt:1822/64930Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:04:12.872526Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Nanomedicines for the delivery of antimicrobial peptides (AMPs)
title Nanomedicines for the delivery of antimicrobial peptides (AMPs)
spellingShingle Nanomedicines for the delivery of antimicrobial peptides (AMPs)
Teixeira, Maria C.
antimicrobial peptides
bacterial and virus infections
coronavirus
antimicrobial resistance
nanomaterials
nanomedicine
Science & Technology
title_short Nanomedicines for the delivery of antimicrobial peptides (AMPs)
title_full Nanomedicines for the delivery of antimicrobial peptides (AMPs)
title_fullStr Nanomedicines for the delivery of antimicrobial peptides (AMPs)
title_full_unstemmed Nanomedicines for the delivery of antimicrobial peptides (AMPs)
title_sort Nanomedicines for the delivery of antimicrobial peptides (AMPs)
author Teixeira, Maria C.
author_facet Teixeira, Maria C.
Carbone, Claudia
Sousa, Maria C.
Espina, Marta
Garcia, Maria L.
Sanchez-Lopez, Elena
Souto, Eliana B.
author_role author
author2 Carbone, Claudia
Sousa, Maria C.
Espina, Marta
Garcia, Maria L.
Sanchez-Lopez, Elena
Souto, Eliana B.
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Teixeira, Maria C.
Carbone, Claudia
Sousa, Maria C.
Espina, Marta
Garcia, Maria L.
Sanchez-Lopez, Elena
Souto, Eliana B.
dc.subject.por.fl_str_mv antimicrobial peptides
bacterial and virus infections
coronavirus
antimicrobial resistance
nanomaterials
nanomedicine
Science & Technology
topic antimicrobial peptides
bacterial and virus infections
coronavirus
antimicrobial resistance
nanomaterials
nanomedicine
Science & Technology
description Microbial infections are still among the major public health concerns since several yeasts and fungi, and other pathogenic microorganisms, are responsible for continuous growth of infections and drug resistance against bacteria. Antimicrobial resistance rate is fostering the need to develop new strategies against drug-resistant superbugs. Antimicrobial peptides (AMPs) are small peptide-based molecules of 5–100 amino acids in length, with potent and broad-spectrum antimicrobial properties. They are part of the innate immune system, which can represent a minimal risk of resistance development. These characteristics contribute to the description of these molecules as promising new molecules in the development of new antimicrobial drugs. However, efforts in developing new medicines have not resulted in any decrease of drug resistance yet. Thus, a technological approach on improving existing drugs is gaining special interest. Nanomedicine provides easy access to innovative carriers, which ultimately enable the design and development of targeted delivery systems of the most efficient drugs with increased efficacy and reduced toxicity. Based on performance, successful experiments, and considerable market prospects, nanotechnology will undoubtedly lead a breakthrough in biomedical field also for infectious diseases, as there are several nanotechnological approaches that exhibit important roles in restoring antibiotic activity against resistant bacteria.
publishDate 2020
dc.date.none.fl_str_mv 2020-03-20
2020-03-20T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/64930
url http://hdl.handle.net/1822/64930
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Teixeira, Maria C.; Carbone, Claudia; Sousa, Maria C.; Espina, Marta; Garcia, Maria L.; Sanchez-Lopez, Elena; Souto, Eliana, Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs). Nanomaterials, 10(3), 560, 2020
2079-4991
10.3390/nano10030560
http://www.mdpi.com/journal/nanomaterials
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132450175057920